PE70198A1 - Analogos de vitamina d3 - Google Patents

Analogos de vitamina d3

Info

Publication number
PE70198A1
PE70198A1 PE1997000398A PE00039897A PE70198A1 PE 70198 A1 PE70198 A1 PE 70198A1 PE 1997000398 A PE1997000398 A PE 1997000398A PE 00039897 A PE00039897 A PE 00039897A PE 70198 A1 PE70198 A1 PE 70198A1
Authority
PE
Peru
Prior art keywords
compounds
insurance
loss
formula
analogs
Prior art date
Application number
PE1997000398A
Other languages
English (en)
Inventor
Andrew David Batcho
Graeme Findlay Bryce
Bernard Michael Hennessy
Jerome Anthony Iacobelli
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE70198A1 publication Critical patent/PE70198A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: SI R ES H, F o OH; R2 ES H, ALQUILO INFERIOR O HALOGENO, DE PREFERENCIA METILO, ETILO O FLUORO; "X" ES =CH2 O CUANDO R ES OH, "X" ES (H,H) o =CH2; "A" ES -C�C-, -CH=CH- o -CH2-CH2- CON LA CONDICION DE QUE CUANDO "A" ES -CH2-CH2- R2 ES H o ALQUILO INFERIOR. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS DE FORMULA (I), QUE COMPRENDE DESPROTEGER COMPUESTOS CORRESPONDIENTES QUE CONTIENEN GRUPOS HIDROXI SILIL PROTEGIDOS. LOS COMPUESTOS OBTENIDOS ADEMAS DE SER UTILES EN EL TRATAMIENTO DE ENFERMEDADES DE LA PIEL HIPERPROLIFERATIVAS TAL COMO PSORIASIS, CARCINOMA DE CELULAS BASALES, TRANSTORNOS DE QUERATINIZACION Y QUERATOSIS, PROPORCIONAN EFECTOS ANTIENVEJECIMIENTO Y ANTIARRUGA, ASI COMO FAVORECEN LA RESTAURACION DE LA PIEL DANADA POR EL SOL
PE1997000398A 1996-05-23 1997-05-20 Analogos de vitamina d3 PE70198A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1815396P 1996-05-23 1996-05-23
US1818696P 1996-05-23 1996-05-23
US3990097P 1997-03-19 1997-03-19

Publications (1)

Publication Number Publication Date
PE70198A1 true PE70198A1 (es) 1998-11-26

Family

ID=27360973

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000398A PE70198A1 (es) 1996-05-23 1997-05-20 Analogos de vitamina d3

Country Status (29)

Country Link
EP (2) EP1464640A3 (es)
JP (1) JP2859247B2 (es)
KR (1) KR100783856B1 (es)
CN (1) CN1176072C (es)
AR (1) AR007241A1 (es)
AT (1) ATE277008T1 (es)
AU (1) AU723929B2 (es)
BR (1) BR9703384A (es)
CA (1) CA2205275C (es)
CO (1) CO4950531A1 (es)
CZ (1) CZ157897A3 (es)
DE (1) DE69730774T2 (es)
DK (1) DK0808833T3 (es)
ES (1) ES2227635T3 (es)
HR (1) HRP970273A2 (es)
HU (1) HUP9700926A3 (es)
IL (1) IL120843A0 (es)
MA (1) MA24251A1 (es)
NO (1) NO972304L (es)
NZ (1) NZ314839A (es)
PE (1) PE70198A1 (es)
PL (1) PL320132A1 (es)
PT (1) PT808833E (es)
SG (1) SG70009A1 (es)
TR (1) TR199700415A2 (es)
TW (1) TW445252B (es)
UY (1) UY24561A1 (es)
YU (1) YU20197A (es)
ZA (1) ZA974336B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939408A (en) 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
IL131543A (en) * 1997-02-25 2005-08-31 Univ Michigan Cosmetic methods and compositions for preventing and treating chronological aging in human skin
AU743514B2 (en) * 1997-05-16 2002-01-24 Women & Infants Hospital Cyclic ether vitamin D3 compounds, 1alpha (OH) 3-EPI-vitamin D3 compounds and uses thereof
WO1998051664A1 (en) * 1997-05-16 1998-11-19 Women & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
EP0957098A1 (en) * 1998-05-14 1999-11-17 F. Hoffmann-La Roche Ag Intermediates for the synthesis of 3-epi vitamin D3 metabolites and analogs
US6603030B1 (en) 1999-04-22 2003-08-05 Hoffman-La Roche Inc. Process for producing phosphineoxide vitamin D precursors
EP1178808B2 (en) * 1999-04-23 2019-06-12 Leo Pharma A/S Non-aqueous pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin d, a corticosteroid and a solvent component
US6255501B1 (en) * 1999-04-26 2001-07-03 Hoffman-La Roche Inc. Process for preparing antiosteoporotic agents
AU2058701A (en) * 1999-12-02 2001-06-12 F. Hoffmann-La Roche Ag Esters of vitamin D3 and uses thereof
CA2476224A1 (en) 2003-09-24 2005-03-24 Bioxell Spa Compound and use in treatment
CH698144B1 (fr) * 2003-09-24 2009-05-29 Bioxell Spa Analogue de la vitamine D3
GB2407499B (en) * 2003-11-03 2008-02-27 Bioxell Spa Vitamin D3 analogue for use in the treatment of BPH
US20080039434A1 (en) 2004-03-01 2008-02-14 Bioxell S. P.A. Treatment of Interstitial Cystitis with Vitamin D Compounds
WO2006051106A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
EP1883626B1 (en) * 2005-04-25 2017-10-11 OPKO Ireland Global Holdings, Ltd. Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3
CA2619311A1 (en) * 2005-08-18 2007-02-22 Bioxell S.P.A. Synthesis of 1.alpha.-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol
WO2008091686A2 (en) * 2007-01-25 2008-07-31 Bioxell S.P.A. SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL
CA2688083C (en) 2007-05-30 2015-07-07 Cytochroma Inc. Process for producing phosphine oxide vitamin d precursors
ES2366077B2 (es) * 2010-03-30 2012-06-25 Universidade De Vigo Compuestos quirales, procedimientos de obtención y uso.
JP5738307B2 (ja) * 2010-10-25 2015-06-24 帝人ファーマ株式会社 23−イン−ビタミンd3誘導体
CN105348164B (zh) * 2015-10-29 2017-03-29 无锡福祈制药有限公司 一种1α‑羟基维生素D2的制备方法
CN106748942B (zh) * 2016-11-28 2018-06-29 无锡福祈制药有限公司 度骨化醇类似物wxfq-65及其合成方法
ES2731558B2 (es) * 2018-05-15 2020-03-18 Univ Santiago Compostela Compuestos de interés farmacéutico
CN109738252B (zh) * 2019-01-23 2021-03-09 深圳天辰医疗科技有限公司 25-羟基-维生素d解离液
CN109696435B (zh) * 2019-01-25 2021-03-09 深圳天辰医疗科技有限公司 维生素d的测定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8923B (en) * 1988-01-20 1989-09-27 Hoffmann La Roche 16-dehydro-vitamin d3-derivatives
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
DK0580968T3 (da) * 1992-05-20 1996-10-14 Hoffmann La Roche Fluorerede analoger af vitamin D3
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
JP3228488B2 (ja) * 1993-12-24 2001-11-12 株式会社クラレ 20−エピステロイド誘導体およびその製造方法

Also Published As

Publication number Publication date
NZ314839A (en) 2000-01-28
JP2859247B2 (ja) 1999-02-17
HU9700926D0 (en) 1997-07-28
KR100783856B1 (ko) 2008-05-09
HRP970273A2 (en) 1998-04-30
EP1464640A2 (en) 2004-10-06
CZ157897A3 (en) 1997-12-17
AR007241A1 (es) 1999-10-27
CA2205275A1 (en) 1997-11-23
IL120843A0 (en) 1997-09-30
YU20197A (sh) 1999-09-27
CO4950531A1 (es) 2000-09-01
TW445252B (en) 2001-07-11
EP1464640A3 (en) 2005-01-12
ATE277008T1 (de) 2004-10-15
PT808833E (pt) 2004-11-30
KR970074765A (ko) 1997-12-10
DE69730774D1 (de) 2004-10-28
EP0808833A3 (en) 1998-11-25
PL320132A1 (en) 1997-11-24
NO972304L (no) 1997-11-24
ES2227635T3 (es) 2005-04-01
HUP9700926A3 (en) 1999-05-28
HUP9700926A2 (hu) 1998-01-28
AU2357797A (en) 1997-11-27
SG70009A1 (en) 2000-01-25
NO972304D0 (no) 1997-05-21
UY24561A1 (es) 2000-12-29
TR199700415A3 (tr) 1997-12-21
JPH1045713A (ja) 1998-02-17
ZA974336B (en) 1997-11-24
EP0808833A2 (en) 1997-11-26
DK0808833T3 (da) 2005-01-31
EP0808833B1 (en) 2004-09-22
CN1175573A (zh) 1998-03-11
MX9703774A (es) 1998-06-30
CN1176072C (zh) 2004-11-17
MA24251A1 (fr) 1998-04-01
DE69730774T2 (de) 2005-09-29
TR199700415A2 (xx) 1997-12-21
CA2205275C (en) 2007-04-03
AU723929B2 (en) 2000-09-07
BR9703384A (pt) 1998-09-15

Similar Documents

Publication Publication Date Title
PE70198A1 (es) Analogos de vitamina d3
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
NO304945B1 (no) Forbindelse og anvendelse derav for Õ regulere fethet i hud, samt kosmetisk blanding
MD1632F2 (en) Bicyclic compounds, method of inhibiting the tyrosine kinases receptors as epidermal growth factor, pharmaceutical composition, methods of preventing blastocyte implantation and treatment of mammals
ES486349A1 (es) Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas
HK1004663A1 (en) Formulations and methods for reducing skin irritation
BR9709427A (pt) Oxa ácidos e compostos relacionados para tratamento de condições da pele
PE53997A1 (es) Tisu suave conteniendo compuestos de glicerina y amonio cuaternario
AR245700A1 (es) Nuevos derivados de la 2-anilino-pirimidina como agentes antiparasitarios.
ZA914148B (en) Tinctorial composition based on 5,6-dihydroxyindolines and method for dyeing keratinous fibres
HK1108629A1 (en) Compositions comprising an amidine and an alkane polyol
NZ503638A (en) Use of tryptophan and analogs as plant growth regulators
IL69912A (en) Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents
ZA846355B (en) Organosilicon compounds and preparation and use thereof
DK0580968T3 (da) Fluorerede analoger af vitamin D3
PE120899A1 (es) Derivados de d-homo-9,10-seco-colesta-23-in-3,25-diol
AU1498295A (en) MDR resistance treatment
DE69814109D1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
ES8306745A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-piperazino pirimioina.
GB2115815B (en) Benzothiazoline compounds
EP0251014A3 (en) 2-trifluoromethyl benzimidazoles
AU2002215973A1 (en) Compositions comprising hydrophobic silicone oils and alkyl ether carboxylates
JPS5746982A (en) 1,3-dioxane-5yl-alkyltriazole, plant growth regulant containing same and plant growth regulation thereby
KR970074764A (ko) 불소화된 비타민 d₃ 동족체
DE69006647D1 (de) 5,6,7,8-Tetrahydro-1-naphthalenolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Antioxidationsmittel in kosmetischen und pharmazeutischen Zusammensetzungen.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed